Adamas Pharmaceuticals Inc (25) | Business Finance (8)
Browse by Subcategory
Recent Contracts
-
First Amendment to Asset Purchase Agreement by and between Adamas Pharmaceuticals, Inc. and Osmotica Pharmaceutical US LLC
(Filed With SEC on August 9, 2021)
-
Binding Term Sheet by and between Adamas Pharma, LLC and Zydus Worldwide DMCC and Zydus Pharmaceuticals (USA) Inc
(Filed With SEC on May 10, 2021)
-
Underwriting Agreement, dated February 24, 2021, by and between the Company and SVB Leerink LLC and William Blair & Company, L.L.C., as representatives of the underwriters named...
(Filed With SEC on February 25, 2021)
-
Amendment No. 3 to the Loan Agreement dated December 1, 2020 between Adamas Pharma, LLC and Healthcare Royalty Partners III, L.P
(Filed With SEC on February 23, 2021)
-
Description of Capital Stock
(Filed With SEC on February 25, 2020)
-
Asset Purchase Agreement by and between Adamas Pharmaceuticals, Inc. and Osmotica Pharmaceutical US LLC
(Filed With SEC on February 23, 2021)
-
Amendment No. 2 to the Loan Agreement dated January 2, 2020 between Adamas Pharma, LLC and Healthcare Royalty Partners III, L.P
(Filed With SEC on February 25, 2020)
-
Binding Term Sheet by and between Adamas Pharma, LLC and Sandoz, Inc
(Filed With SEC on February 25, 2020)